glimepiride

FDA Drug Profile — Glimepiride

glimepiride is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Glimepiride. Available dosage form: tablet.

Drug details

Generic Name
glimepiride
Brand Names
Glimepiride
Application Number
ANDA077370
Sponsor
Solco Healthcare U.S., LLC
NDC Codes
3
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
GLIMEPIRIDE

Indications and Usage

1 INDICATIONS AND USAGE Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1)] . Limitations of Use Glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. Glimepiride is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (1) . Limitations of Use: Not for treating type 1 diabetes mellitus or diabetic ketoacidosis ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.